Company: BNBX
Filing Date: 2025-09-29
Form Type: 8-K
Source: 0001104659-25-094465
Chunk: 0

Company: BNB PLUS CORP.
Filing Date: 2025-09-29
Form: 8-K
Item: Item 1.01
Chunk 0
---
Item 1.01 Entry into a Material Definitive Agreement.

Securities Purchase Agreement

On September 29, 2025, Applied DNA Sciences, Inc.,
a Delaware corporation (the “ Company”) entered into a securities purchase agreement (the “ Cash Securities Purchase Agreement”)
with certain accredited investors (the “ Cash Purchasers”) pursuant to which the Company agreed to sell and issue to the Cash
Purchasers in a private placement offering (the “ Cash Offering”) an aggregate of 4,730,178 shares (the “ Shares”)
of common stock of the Company, par value $0.001 per share (the “ Common Stock”), and/or prefunded warrants in lieu thereof
(the “ Prefunded Warrants”), and Series E Warrants (the “ Common Warrants”) to purchase 4,730,178 shares of Common
Stock at a per share exercise price of $3.82. In the Cash Offering, the Purchasers will tender U. S. dollars or the cryptocurrency stablecoin
issued by Circle Internet Group, Inc. commonly referred to as “ USDC” to the Company as consideration for the Shares and/or
Prefunded Warrants and the Common Warrants. Lucid Capital Markets, LLC (the “ Placement Agent”) is acting as sole placement
agent for the Offering (as defined below).

Also on September 29, 2025, the Company entered
into a securities purchase agreement (the “ Cryptocurrency Securities Purchase Agreement,” and together with the Cash Securities
Purchase Agreement, the “ Securities Purchase Agreement”) with certain accredited investors (the “ Cryptocurrency Purchasers,”
and together with the Cash Purchasers, the “ Purchasers”) pursuant to which the Company agreed to sell and issue to the Cryptocurrency
Purchasers in a private placement offering (the “ Cryptocurrency Offering,” and together with the Cash Offering, the “ Offering”)
3,334,471 prefunded warrants (the “ Cryptocurrency Prefunded Warrants”) to purchase shares of Common Stock at a per share exercise
price of $3.82 and 3,334,471 common stock purchase warrants (the “ Cryptocurrency Common Warrants”) at a per share exercise
price of $3.82. In the Cryptocurrency Offering, the Cryptocurrency Purchasers will tender cash equivalents of crypto-currency (or trust
units or interests that that hold crypto-currency) acceptable (in form and value) to the Company as consideration for the Cryptocurrency
Common Warrants and the Cryptocurrency Prefunded W